← Back to Clinical Trials
Recruiting NCT03496636

Autologous Ovarian Tissue Transplantation

Trial Parameters

Condition Female Infertility
Sponsor University of Pittsburgh
Study Type INTERVENTIONAL
Phase N/A
Enrollment 5
Sex FEMALE
Min Age 18 Years
Max Age 45 Years
Start Date 2021-03-01
Completion 2026-09-01
Interventions
Ovarian tissue transplant

Brief Summary

Chemotherapy and radiation for cancer and other conditions can cause infertility. Several centers around the world are cryopreserving ovarian tissue from these patients though an experimental protocol, including the Fertility Preservation Program in Pittsburgh (protocol PRO08050491). The objective of this study is to study the efficacy and safety of autologous tissue transplantation in patients diagnosed with primary ovarian insufficiency after chemotherapy and/or radiation treatments.

Eligibility Criteria

Inclusion Criteria: * Previously cryopreserved ovarian tissue * Ovarian insufficiency and/or candidate for pregnancy * Good health * Oncologist's clearance Exclusion Criteria: * Patients considered to be high risk for surgical complications * Women with contraindication for pregnancy if goal is to achieve pregnancy * Women positive for the BRCA mutations * Women with a history of leukemia, ovarian cancer or a cancer that likely involved ovaries at the time of ovarian tissue collection * Women with psychological, psychiatric, or other conditions which prevent giving fully informed consent * Current pregnancy

Related Trials